Guidance for Personal Protective Equipment (PPE)CDC
1 October 2024
This guidance refers only to the following viral hemorrhagic fevers: Ebola, Marburg, Lassa, Crimean Congo Hemorrhagic Fever (CCHF), and the South American Hemorrhagic Fevers (i.e., those caused by Junin, Machupo, Chapare, Guanarito and Sabia viruses).
Marburg virus diseaseWorld Health Organization (WHO)
This is a reference wensite including WHO’s approach to responding to this outbreak
First Marburg Virus Disease Outbreak in the Republic of RwandaCDC / Health Alert Network (HAN)
3 October 2024
This report summarizes CDC’s recommendations for public health departments and clinicians in the United States on case identification and testing and clinical laboratory biosafety considerations.
Marburg Virus Disease Outbreak in RwandaAfricaCDC
1 October 2024
This is a reference website for resources including a “Weekly Special Press Briefing on the Mpox Outbreak and other Health Emergencies in Africa”
12/11/2023: Lab Advisory: Clinical Testing Guidance for Patients with Suspected Viral Hemorrhagic FeversCDC / Laboratory Outreach Communication System (LOCS)
11 December 2023
While the risk of VHFs being brought into the US by travelers is very low, CDC recommends that clinical laboratories review the testing guidance in this article for ebolaviruses, marburgviruses, Crimean-Congo hemorrhagic fever virus, arenaviruses (Lassa, Lugo, and South American hemorrhagic fever viruses), and Nipah virus.
Marburg Virus Disease Outbreaks in Equatorial Guinea and TanzaniaCDC / Health Alert Network (HAN)
6 April 2023
Alert concerning two confirmed outbreaks of Marburg virus disease (MVD)—one in Equatorial Guinea and one in Tanzania.
Marburg Virus Disease Detected in West Africa for First TimeThe Scientist
10 August 2021
The finding of the Ebola-like disease, which killed a man in Guinea, has prompted public health measures.
